Inhalis
Lugano, CH · 1 known investors
Find your way into Inhalis
Sign up to find every way you can get introduced to Inhalis
- Your email: who you already know at Inhalis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Inhalis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Inhalis Therapeutics researches and develops inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases, using inhalation delivery technology. It focuses on providing safer and more effective therapy options for patients.
Investors · 1
Frequently asked questions
- What does Inhalis do?
- Inhalis Therapeutics researches and develops inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases, using inhalation delivery technology. It focuses on providing safer and more effective therapy options for patients.
- Who are Inhalis's investors?
- Inhalis's investors include TiVenture SA.
- Where is Inhalis headquartered?
- Inhalis is headquartered in Lugano, CH.
